Kyoto, Japan

Eigo Otsuji

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto Prefectural Public University Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eigo Otsuji. Retrieved from https://idiyas.com/inventor/eigo-otsuji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eigo Otsuji: Innovator in Tumor Identification Technology

Introduction

Eigo Otsuji is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical technology, particularly in the identification of tumor sites. His innovative approach combines spectroscopy and fluorescence detection to enhance the accuracy of tumor identification.

Latest Patents

Otsuji holds a patent for a "Tumor site or parathyroid gland identification device and method." This invention provides a device that spectroscopically detects the fluorescence of protoporphyrins present in tumor sites. This technology aims to improve the precision of tumor identification, which is crucial for effective treatment.

Career Highlights

Eigo Otsuji is affiliated with the Kyoto Prefectural Public University Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical diagnostics and treatment methodologies.

Collaborations

Otsuji has collaborated with esteemed colleagues, including Noriaki Koizumi and Tetsuro Takamatsu. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Eigo Otsuji's contributions to tumor identification technology exemplify the importance of innovation in medical science. His work not only advances the field but also holds promise for improving patient outcomes in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…